DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Lameijer M, Binderup T, van Leent MMT. et al.
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.
Nat Biomed Eng 2018;
2 (05) 279-292
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.